Merit Medical Systems Inc (MMSI)
Return on assets (ROA)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 94,411 | 100,183 | 89,621 | 84,674 | 74,516 | 61,728 | 58,423 | 48,041 | 48,454 | 43,219 | 28,243 | 4,269 | -9,843 | -29,426 | -29,815 | -3,898 | 5,451 | 18,844 | 38,861 | 42,943 |
Total assets | US$ in thousands | 2,325,240 | 1,808,500 | 1,837,570 | 1,684,110 | 1,663,970 | 1,632,740 | 1,631,520 | 1,629,740 | 1,648,290 | 1,643,170 | 1,642,390 | 1,651,720 | 1,664,400 | 1,670,510 | 1,715,870 | 1,749,270 | 1,757,320 | 1,761,700 | 1,736,270 | 1,689,790 |
ROA | 4.06% | 5.54% | 4.88% | 5.03% | 4.48% | 3.78% | 3.58% | 2.95% | 2.94% | 2.63% | 1.72% | 0.26% | -0.59% | -1.76% | -1.74% | -0.22% | 0.31% | 1.07% | 2.24% | 2.54% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $94,411K ÷ $2,325,240K
= 4.06%
The return on assets (ROA) for Merit Medical Systems, Inc. has shown a generally positive trend over the past eight quarters, ranging from 2.95% in Q1 2022 to 5.54% in Q3 2023. This indicates that the company has been effectively utilizing its assets to generate profits during this period. The ROA peaked in Q3 2023, suggesting an improvement in the company's efficiency in generating earnings relative to its assets. Overall, the increasing trend in ROA demonstrates Merit Medical Systems' ability to generate better returns on its investment in assets over time.
Peer comparison
Dec 31, 2023
Company name
Symbol
ROA
Merit Medical Systems Inc
MMSI
4.06%
3M Company
MMM
-13.83%
Artivion Inc
AORT
-3.87%
Baxter International Inc
BAX
9.39%
Becton Dickinson and Company
BDX
2.98%
Boston Scientific Corp
BSX
4.53%
DexCom Inc
DXCM
8.64%
Embecta Corp
EMBC
6.09%
Glaukos Corp
GKOS
-14.32%
Globus Medical
GMED
2.42%
Haemonetics Corporation
HAE
5.35%